top of page

Free Biopharma Daily Stock Updates - 07/16/21

$XBI $125.9 0.0%

 

Want to access our searchable Catalyst Calendar of over 1,000 biotech stock events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!

 

Covid Updates

$BNTX +4.7% U.S. FDA Grants Priority Review for the Biologics License Application for Pfizer-BioNTech COVID-19 Vaccine. source


$IBIO +0.8% iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate. source


Pipeline Updates

$KDMN +20.6% U.S. FDA Grants Full Approval of REZUROCK(TM) (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD). source


$FATE +2.4% Fate Therapeutics to Host Virtual Event Highlighting Interim Phase 1 Clinical Data from its Off-the-Shelf, iPSC-derived NK Cell Franchise for B-cell Lymphoma. source


$HCM +3.7% HUTCHMED’s Marketing Authorization Application for Surufatinib Submitted and Validated by the European Medicines Agency. source


$FGEN -42.2% FibroGen Announces Outcome of FDA Advisory Committee Review of Roxadustat for Treatment of Anemia of Chronic Kidney Disease. source


Financial Updates

$ENDP +1.7% Endo Comments on Tennessee Appeals Court Orders. source


$ATOS -19.9% Atossa in selloff for second straight session after sharp run-up this year. source


 

Posted by FS

0 comments

Comentarios


bottom of page